Clinical Trial Update: Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period [Phase 1]

View source ↗

Summary

Phase I, open-label, single-dose four-way crossover study comparing the pharmacokinetics of NP101 with oral sumatriptan (Imitrex) in migraine subjects during an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imitrex (Sumatriptan)
• NP101

Snippet

Sponsor: NuPathe Inc. | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED